Annual Information Update

RNS Number : 0363N
Assura Group Limited
22 July 2014
 



22 July 2014

 For immediate release

Assura Group Limited

Annual Information Update

In accordance with Prospectus Rule 5.2, Assura Group Limited (the "Company") sets out below a summary of the information which has been published or made available to the public during the period 21 July 2013 to 20 July 2014.

This annual information update is required by and is being made pursuant to Article 10 of the Prospectus Directive (Prospective Rule 5.2) and not for any other purpose. Information is referred to in this update rather than included in full. The information referred to was up to date at the time it was published; however, some information may now be out of date.

 1.         Regulatory Announcements

 The following UK regulatory announcements have been issued through RNS, a Regulatory News Service. They can be viewed or downloaded from the London Stock Exchange website (www.londonstockexchange.com) in the Market News section, searching under the Company's code AGR.

Date

Announcement

22 July 2013

Annual Report 2013

24 July 2013

Annual Information Update

12 August 2013

Interim Management Statement

16 August 2013

Appointment of Joint Corporate Broker

20 August 2013

Holding(s) in Company

11 September 2013

Acquisition of 32 medical centres for £62.5m

19 September 2013

Results of AGM

3 October 2013

Confirmation of Quarterly Interim Dividend

14 October 2013

Notifications of Major Interests in Shares

5 November 2013

Notification of Major Interest in Shares

5 November 2013

Director Declaration

25 November 2013

Sale of LIFT Investments

26 November 2013

Interim Results 2013

27 November 2013

Director/PDMR shareholding

27 November 2013

Director/PDMR shareholding

3 December 2013

Notification of Major Interest in Shares

3 December 2013

Director/PDMR shareholding

9 December 2013

Notification of Major Interest in Shares

9 December 2013

Notification of Major Interest in Shares

10 December 2013

Notification of Major Interest in Shares

11 December 2013

Notification of Major Interest in Shares

12 December 2013

Notification of Major Interest in Shares

20 December 2013

Confirmation of Quarterly Interim Dividend

2 January 2014

Director/PDMR shareholding

24 January 2014

Sale of LIFT Investments

24 January 2014

Director/PDMR shareholding

29 January 2014

Notification of Vesting of Share Award to PDMR

11 February 2014

Notification of Major Interest in Shares

13 February 2014

Notification of Major Interest in Shares

14 February 2014

Interim Management Statement

4 March 2014

Director/PDMR shareholding

2 April 2014

Confirmation of Quarterly Interim Dividend

23 May 2014

Preliminary results for the year ended 31 March 2014

10 June 2014

Confirmation of Quarterly Interim Dividend

13 June 2014

Acquisition of 28 medical centres for £107 million

20 June 2014

Annual Report & Notice of AGM

23 June 2014

Notification of Major Interest in Shares

1 July 2014

Notification of Major Interest in Shares

1 July 2014

Total Voting Rights and Issued Share Capital

  2.         Documents filed at Companies House                                                                     

Date

Announcement

16 August 2013

Group of Companies Accounts made up to 31/03/13

24 December 2013

BR010010 Business Change 09/12/13 Managing of Operations of the Group's Property, Pharmacy & Medical Business

24 December 2013

Change in objects 09/12/13 Healthcare Services


3.         Annual and interim reports

The Company's annual report for the year ended 31 March 2013, interim report for the six months to 30 September 2013 and annual report for the year ending 31 March 2014 can be downloaded from the Company's website at http://www.assuragroup.co.uk/investor-relations/reports-presentations/2014.aspx.

A copy of this annual information update and all documents referred to in it can be obtained from the Company's branch address:

Assura Group Limited

The Brew House

Greenalls Avenue

Warrington

Cheshire

WA4 6HL

 For further information, please contact:

Jonathan Murphy

Company Secretary

Assura Group Limited

Tel: 01925 420660

 

Notes to Editors

Assura Group is a long-term investor in and developer of primary care property.  The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community.  At 31 March 2014, Assura Group's property portfolio was valued at £668m.

 

Further information is available at www.assuragroup.co.uk 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUUUUNRSBABUAR

Companies

Assura (AGR)
UK 100

Latest directors dealings